With the TRIPS agreement, intellectual property rights have been integrated into the multilateral trading system for the first time and remains the most comprehensive multilateral IP agreement to date. In 2001, developing countries, fearing that developed countries had insisted on too narrow a reading of the TRIPS trip, launched a series of discussions that culminated in the Doha Declaration. The Doha Declaration is a WTO DECLARATION that clarifies the scope of the TRIPS agreement, which states, for example, that TRIPS can and should be interpreted in light of the objective of “promoting access to medicines for all”. Although the United Kingdom is a member of the World Trade Organization and a signatory to the (plurilateral) agreement on civil air trade, it is currently bound by the three protocols that this report considers only as a Member State of the European Union. This obvious discrepancy can be explained by the fact that the content of international trade agreements and the extent of EU powers have evolved over time. The United Kingdom indicated that the provisions of the EU`s regional trade agreements would continue to apply to trade with the United Kingdom during the transitional period of the withdrawal agreement. For more information, see WT/GC/206 and the EU Note (WT/LET/1462), which informs WTO members that the UK will be treated as a member state of the European Union for relevant international agreements during the transition period. 24.The Trade-Related Intellectual Property Rights Agreement (TRIPS), which came into force on 1 January 1995, is a comprehensive multilateral agreement on intellectual property among all members of the World Trade Organization (WTO). It sets minimum standards for the regulation of many forms of intellectual property by national governments. An agreement reached in 2003 relaxed domestic market requirements and allows developing countries to export to other countries with a public health problem as long as exported drugs are not part of a trade or industrial policy. [10] Drugs exported under such regulations may be packaged or coloured differently to prevent them from affecting the markets of industrialized countries.

Share →